CoryLGambleDOFACOI, FACE
Endocrinology • Fort Smith, ARDiabetes, Lipid Metabolism
US Medical Lead Victoza
Dr. Gamble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6801 Rogers Ave
Fort Smith, AR 72903Phone+1 479-452-2077
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
Oklahoma State University Center for Health SciencesClass of 1982
Certifications & Licensure
OK State License 1984 - 2023
AR State License 1983 - 2021
Publications & Presentations
PubMed
- 1 citationsReal-world HbAchanges and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes.Monica Frazer, Caroline Swift, Andrew Sargent, Michael Leszko, Erin Buysman
Journal of Diabetes and Metabolic Disorders. 2024-06-01 - 1 citationsReal-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glyc...Xi Tan, Victoria Divino, James Amamoo, Lin Xie, Katharine B Coyle
Clinical Drug Investigation. 2024-04-01 - 1 citationsDurability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP-4i) in US Adults with Type 2 Diabetes.Xi Tan, Yuanjie Liang, Cory Gamble, Aaron King
Diabetes Therapy. 2024-02-01
Professional Memberships
- Member
Industry Relationships
- US Medical Director Victoza, Novo Nordisk Inc2008 - 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
